In this study, we planned to evaluate the comparison of serum prolidase activity with other biochemical markers.
The patient group was consisted of totally 73 patients with 21 male and 18 female who were diagnosed as chronic renal failure (CRF) and were undergoing peritoneal dialysis while 21 male and 13 female who were undergoing hemodialysis. The control group was composed of 54 healthy volunteers, including 25 men and 29 women. Serum and erythrocyte prolidase activities were measured in both patient and control groups and the relationship between serum prolidase activities and metabolic markers of bone (osteocalcin, bone-specific alkaline phosphatase, calcitonin, vitamin D and parathormone) were compared in both groups.
There was a significant difference between the serum prolidase activity of peritoneal dialysis and pre-hemodialysis groups as compared with the control group (p<0.05). Serum prolidase activity of the pre-hemodialysis group was lower than that of post-hemodialysis group and there was a statistically significant difference (p<0.05). There was a significant difference between prolidase activities in erythrocytes of prehemodialysis and control groups (p<0.05).
Kidney is the most prolidase-rich tissue in the human body. According to our results, the prolidase activity decreased in CRF; and the level of decrement was independent from the hemodialysis procedure.
Myara I, Cosson C, Moatti N, Lemonnier A. Human kidney prolidase –purification, preincubation properties and immunological reactivity. Int J Biochem 1994;26:207–14.817475610.1016/0020-711X(94)90147-3)| false
Myara I, Myara A, Mangeat M, Fabre M, Charpentier C, Lemonnier A. Plasma prolidase activity. A possible index of collagen catabolism in chronic liver disease. Clin Chem 1984;30:211–5.669252510.1093/clinchem/30.2.211)| false
Ureña P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 1996;7:506–12.8704118)| false
Coen G, Ballanti P, Mazzaferro S, Pasquali M, Bonucci E. Procollagen type I C-terminal peptide, PTH and 1, 25 (OH)2 D3 in chronic renal failure. Bone 1993;14:415–20.10.1016/8756-3282(93)90173-88161367)| false
Erbağcı AB, Araz M, Erbağcı A, Tarakçıoğlu M, Namıdur ES. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin Biochem 2002;35:263–8.10.1016/S0009-9120(02)00305-312135686)| false
Verit FF, Geyikli I, Yazgan P, Celik A. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Arch Gynecol Obstet 2006;274:133–7.10.1007/s00404-006-0148-916532321)| false
Turkish Journal of Biochemistry (TJB), official journal of Turkish Biochemical Society, is issued electronically every 2 months. The main aim of the journal is to support the research and publishing culture by ensuring that every published manuscript has an added value and thus providing international acceptance of the “readability” of the manuscripts published in the journal.